NCT06192082

Brief Summary

This study aims to compare the effects of conscious sedation and intravenous general anesthesia on cardiovascular events in frail patients undergoing digestive endoscopy diagnosis and treatment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
226

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2026

Completed
Last Updated

February 12, 2026

Status Verified

November 1, 2025

Enrollment Period

2.1 years

First QC Date

November 27, 2023

Last Update Submit

February 11, 2026

Conditions

Keywords

gastroscopyfrail patientsadverse cardiovascular events

Outcome Measures

Primary Outcomes (1)

  • Adverse cardiovascular events

    The occurrence rate of heart rate abnormal events (defined as heart rate abnormal events with a baseline fluctuation of ± 30%);The incidence of blood pressure fluctuation events (defined as blood pressure fluctuation events with a baseline blood pressure fluctuation of ± 30%);The incidence of angina, myocardial infarction, cardiac arrest, acute heart

    during the examination and recovery room time(up to 2 hours)

Secondary Outcomes (3)

  • The incidence of other adverse events

    during the examination and recovery room time(up to 2 hours)

  • VAS score

    during the examination and recovery room time(up to 2 hours)

  • Satisfaction score

    during the examination and recovery room time(up to 2 hours)

Study Arms (2)

The conscious sedation group

EXPERIMENTAL

conscious sedation

Procedure: The conscious sedation group

Intravenous general anesthesia group

ACTIVE COMPARATOR

Intravenous general anesthesia

Procedure: Intravenous general anesthesia group

Interventions

Intravenous general anesthesia group (Group B): sufentanil 0.05-0.1 μ G/kg, administration time 30 seconds, 1mg/kg of propofol administered 2 minutes before examination. Depending on the patient's sleep status, 10mg of propofol can be administered every 30 seconds; Evaluate the patient's MOAA/S score. At 0-1 points, a digestive endoscope is inserted. If there is coughing or physical activity during the examination that the patient cannot tolerate, propofol 10-20mg can be administered multiple times. Evaluate the MOAA/S score again, and continue the operation after 0-1 points.

Also known as: Group B
Intravenous general anesthesia group

The conscious sedation group (Group A) received sufentanil 0.05-0.1 5 minutes before examination μ G/kg, administration time 30 seconds, 1-2 mg of midazolam administered 2 minutes before examination; Evaluate the patient's MOAA/S score, insert a digestive endoscope at 2-3 minutes, and add 1-2mg of midazolam if the patient is unable to tolerate coughing or movement during the examination. Reevaluate the MOAA/S score, and continue the operation after 2-3 minutes;

Also known as: Group A
The conscious sedation group

Eligibility Criteria

Age65 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age greater than 65 years old, regardless of gender
  • ASA is classified as Class II and III;
  • BMI 18-28 kg/m2;
  • Patients undergoing examination or treatment outside the operating room;
  • FRAIL scale score ≥ 3 points 6 The patient voluntarily participated in this study and signed an informed consent form.

You may not qualify if:

  • Those who are allergic or contraindicated to drugs such as benzodiazepines, opioids, propofol, and their drug components;
  • \. Acute heart failure; Unstable angina pectoris; Myocardial infarction occurred within 6 months prior to screening; Resting electrocardiogram heart rate\<50 beats/minute; Third degree atrioventricular transmission delay; Severe arrhythmia; Moderate to severe heart valve disease;
  • \. Patients with severe respiratory diseases (acute respiratory infections, acute exacerbations of chronic obstructive pulmonary disease, uncontrolled asthma, etc.);
  • \. Patients who have not received formal antihypertensive treatment or have poor blood pressure control;
  • \. Patients with traumatic brain injury, possible presence of intracranial hypertension, cerebral aneurysms, history of cerebrovascular accidents, and central nervous system diseases;
  • \. Individuals with mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.), long-term history of taking psychotropic drugs, and cognitive impairment;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, 100050, China

RECRUITING

Related Publications (1)

  • Liu X, Hou H. Impact of anesthesia methods on adverse cardiovascular events during painless gastroscopy in frail older patients: study protocol for a prospective controlled trial. Front Med (Lausanne). 2026 Mar 5;13:1784922. doi: 10.3389/fmed.2026.1784922. eCollection 2026.

Central Study Contacts

Haijun Hou, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
On the premise of ensuring clinical work and safety, in order to objectively evaluate the research results, the single blind method is reasonably used in this project. Patients are unaware of the anesthesia plan, and preoperative data collection and implementation of the anesthesia plan are carried out by experienced anesthesiologists who have undergone detailed training. Postoperative PACU clinical data and postoperative follow-up were followed up by another anesthesiologist who was unaware of the trial group over the phone.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Using a stratified randomization method, the candidate subjects were divided into two groups: the conscious sedation group (Group A); Intravenous general anesthesia group (Group B); There are 113 cases in each group, with a total of 226 cases in both groups. The computer generated random group numbers will be printed and placed in a separate sealed envelope. When accepting subjects who meet the inclusion criteria, the anesthesiologist will assign the newly recruited subjects to the corresponding groups based on the number in the envelope, and the anesthesiologist will be responsible for recording the physiological characteristics of the patients. Another anesthesiologist followed up the patient after the surgery. Both the follow-up doctor and the patient are unaware of the treatment plan. In emergency situations, anesthesiologists can change the anesthesia method to ensure clinical safety and truthfully record it.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2023

First Posted

January 5, 2024

Study Start

January 1, 2024

Primary Completion

February 12, 2026

Study Completion

February 12, 2026

Last Updated

February 12, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations